Document is current
Any future updates will be listed below
-
Authors
de Vries, Natasja L. https://orcid.org/0000-0003-4966-7036
van de Haar, Joris
Veninga, Vivien https://orcid.org/0000-0002-5166-5075
Chalabi, Myriam https://orcid.org/0000-0002-8607-6174
Ijsselsteijn, Marieke E.
van der Ploeg, Manon https://orcid.org/0000-0001-7150-3068
van den Bulk, Jitske https://orcid.org/0000-0002-2056-9478
Ruano, Dina
van den Berg, Jose G.
Haanen, John B. https://orcid.org/0000-0001-5884-7704
Zeverijn, Laurien J.
Geurts, Birgit S.
de Wit, Gijs F.
Battaglia, Thomas W.
Gelderblom, Hans https://orcid.org/0000-0001-9270-8636
Verheul, Henk M. W.
Schumacher, Ton N. https://orcid.org/0000-0003-0517-8804
Wessels, Lodewyk F. A. https://orcid.org/0000-0002-1656-6995
Koning, Frits
de Miranda, Noel F. C. C. https://orcid.org/0000-0001-6122-1024
Voest, Emile E. https://orcid.org/0000-0001-8249-9586
- License Information
-
More Information
Article History
Received: 16 July 2021
Accepted: 24 November 2022
First Online: 11 January 2023
Competing interests
: M.C. has performed an advisory role or offered expert testimony for BMS, MSD and NUMAB; has received honoraria from BMS and Roche; and has received financing of scientific research from Roche, BMS and MSD. J.B.H. has received research funding from BMS; and has performed an advisory role for BMS.
